-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
Satellos Bioscience Inc. | 6.430% | -3.933% | 4.908% | 9.615% | 23.913% | -73.281% | - |
Burcon Nutrascience Corp. | 14.570% | 1.887% | -7.429% | 39.655% | 21.805% | -92.636% | -67.060% |
Sirona Biochem Corp. | 14.710% | 10.448% | -1.333% | -58.705% | -43.077% | -77.844% | -89.871% |
News
Klondike Gold Completes 2,750m Drilling at Stander Zone
June 11, 2024 – Vancouver, BC – Klondike Gold Corp. (TSX.V: KG; FRA: LBDP; OTCQB: KDKGF) (“Klondike Gold” or the “Company”) is pleased to announce that it has completed the first phase of
FuelCell Energy Ignites Short-Covering Rally, Don’t Buy Into It
FuelCell Energy (NASDAQ: FCEL) is up a solid 20% following its latest earnings release on dubious news and hope. The move confirms a technical reversal in the share price, but the report's
Meet the 1 Thing That Could Keep Nvidia Ahead of Rivals
Nvidia (NASDAQ: NVDA) is playing a crucial role in the development of artificial intelligence (AI) today thanks to its top-performing graphics processing units (GPUs). These chips power some of the